Clinical trial
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With…
NCT00239655 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00239655 |
|---|---|
| Title | A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED) |
| Official title | A Randomized, Double-Blind Placebo Controlled, Parallel Groups Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by MRI |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Relapsing-Remitting Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | MK0812 |
| Enrollment | 120 |
| Start date | Aug 1, 2004 |
| Primary completion | Dec 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Oct 17, 2005 |
| Last update posted | Aug 1, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: